Inside informationEnglish
Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 25/11/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 110718_20251125